Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

NCT02476617 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Hepatitis C (HCV)
Hepatitis C Genotype 1a

Interventions

DRUG: ombitasvir/paritaprevir/ritonavir
DRUG: dasabuvir
DRUG: ribavirin

Sponsor

AbbVie